Loading...
G54-12 1 Ordinance No. G54-12 AN ORDINANCE CREATING CHAPTER 10.25, ENTITLED "SYNTHETIC ALTERNATIVE DRUGS," OF THE ELGIN MUNICIPAL CODE, 1976, AS AMENDED WHEREAS, the City of Elgin is a home rule unit pursuant to Article VII Section 6 of the Illinois Constitution; and WHEREAS, as a home rule unit the City of Elgin may exercise any power and perform any function pertaining to its government and affairs including, but not limited to, the power to regulate for the protection of the public health, safety, morals and welfare; and WHEREAS, 65 ILCS 5/11-20-5 authorizes the City of Elgin to implement regulations that are necessary or expedient for the promotion of the public health and welfare; and WHEREAS, the City of Elgin has encountered an increase in the possession, distribution, sale, and consumption within its corporate boundaries of products containing compounds originally designed as synthetic alternatives (i.e., synthetic cannabinoids, synthetic stimulants, and synthetic psychedelic/hallucinogens) to prohibited controlled substances such as tetrahydrocannabinol (THC), cathinone, methcathinone, MDMA and MDEA; and • WHEREAS, the City of Elgin finds that products containing synthetic cannabinoids, synthetic stimulants, and synthetic psychedelic/hallucinogens are being purchased for recreational use as an alternative to controlled substances banned at the Federal, State, and local levels; and WHEREAS, the City of Elgin finds that products containing synthetic cannabinoids, synthetic stimulants, and synthetic psychedelic/hallucinogens are particularly attractive to children and young adults due to their availability in small amounts at neighborhood stores at minimal costs, and due to the names being given to these substances which are intended to appeal to children and young adults; and WHEREAS, the Drug Enforcement Administration (''DEA") has determined that the consumption of synthetic cannabinoids have adverse health effects such as agitation, anxiety, nausea, vomiting, tachycardia, elevated blood pressure, tremors, seizures, hallucinations, paranoid behavior and non-responsiveness; and WHEREAS, the DEA has determined that consumption of synthetic stimulants affect alertness and have been linked to severe psychotic episodes, increased heart rates, panic attacks, and hallucinations; and WHEREAS, the American Association of Poison Control Centers has reported that in 2011 there were more than 6,900 synthetic cannabinoid-related calls to poison control centers in 2011, and more than 6,100 reports of cathinone or "bath salt" abuse; and WHEREAS, the City of Elgin deems it necessary and desirable to prohibit the sale, • delivery, possession, use and manufacture of products containing synthetic cannabinoids, synthetic stimulants, and synthetic psychedelic/hallucinogens in order to protect the public and abate a public nuisance; and WHEREAS, the Corporate Authorities of the City of Elgin have determined that it is in the best interests of the City of Elgin and its residents to amend the Elgin Municipal Code to implement regulations relative to the sale, delivery, possession, use and manufacture of such synthetic products as hereinafter set forth: NOW, THEREFORE, BE IT ORDAINED BY THE CITY COUNCIL OF THE CITY OF ELGIN, ILLINOIS: Section 1. That Title 10 of the Elgin Municipal Code, 1976, as amended, entitled "Public Peace, Morals and Welfare," be and is hereby amended by creating Chapter 10.26, entitled, "Synthetic Alternative Drugs," to read as follows: Chapter 10.26 SYNTHETIC ALTERNATIVE DRUGS Sections: 10.26.010: Definitions. 10.26.020: Sale or Delivery. • 10.26.030: Possession. 10.26.040: Use. 10.26.050: Manufacture. 10.26.060: Unlawful to Advertise. 10.26.070: Public Nuisance Declared. 10.26.080: Exemptions. 10.26.090: Penalties. 10.26.010: DEFINITIONS: For purposes of this Chapter, the following definitions shall apply unless the context clearly indicates or requires different meaning: DELIVER or DELIVERY: The actual, constructive, or attempted transfer of possession, with or without consideration, whether or not there is an agency relationship. MANUFACTURE: The production, preparation, propagation, compounding, conversion or processing of a product containing a synthetic cannabinoid, a synthetic stimulant, or a synthetic psychedelic/hallucinogen, either directly or indirectly, by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of such products or labeling of its container, except that this term does not include the preparation, compounding, packaging, or • labeling of such products as an incident to administering or dispensing such products in the 2 course of a person's professional practice, or as an incident to lawful research, teaching, or • chemical analysis and not for sale. SYNTHETIC ALTERNATIVE DRUG: Any product containing a synthetic cannabinoid, a synthetic stimulant, or a synthetic psychedelic/hallucinogen, as those terms are defined herein, including but not limited to those products, brand names or identifiers listed in Table 10.26.010 set forth herein. SYNTHETIC CANNABINOID: Any chemical compound that acts as or contains a cannabinoid receptor agonist that functions similar to the active ingredient in marijuana, tetrahydrocannabinol (THC), including those examples found in the Schedules of Article 11 of the Illinois Control Substances Act (720 ILCS 570/201 et seq.), as amended from time to time, or otherwise prohibited under federal or state law, and further including, but not limited to, any quantity of a natural or synthetic material, compound, mixture or preparation containing the following substances, and their analogs (including isomers (whether optical, positional, or geometric), esters, ethers, salts, and salts of isomers) whenever the existences of these analogs (including isomers (whether optical, positional, or geometric), esters, ethers, salts, and salts of isomers) is possible within the specific chemical designation: Naphthoylindoles. Any compound containing a 3-(1-Naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl group, whether or not further substituted in the indole ring to any • extent and whether or not substituted in the naphthyl ring to any extent, including but not limited to the following: (a) JWH-007 (1-pentyl-2-methyl-3-(1-naphthoyl)indole); (b) JWH-015 ((2-Methyl-l-propyl-lH-indol-3-yl)-1-naphthalenylmethanone); (c) JWH-018 (1-pentyl-3-(1-naphthoyl)indole); (d) JWH-019 (1-hexyl-3-(naphthalen-l-oyl)indole); (e) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone); (f) JWH-081 (4-methoxynaphthalen-l-yl-(1-pentylindol-3-yl)methanone); (g) JWH-098 (4-methoxynaphthalen-l-yl-(1-pentyl-2-methylindol-3-yl)methanone); (h) JWH-122 (1-Pentyl-3-(4-methyl-l-naphthoyl)indole); (i) JWH-164 (7-methoxynaphthalen-l-yl-(1-pentylindol-3-yl)methanone; 0) JWH-200 (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-l-ylmethanone); (k) JWH-210 (4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone; (1) JWH-398 (1-pentyl-3-(4-chloro-l-naphthoyl)indole); (m)WIN 55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de)-1,4-benzoxazin-6-yl]-1-nepthalenylmethanone); (n) AM-2201 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(naphthalen-l-yl)methanone). Naphthylmethylindoles. Any compound containing a 1 H-indol-3-yl-(1- naphthyl) methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, • or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to 3 I any extent and whether or not substituted in the naphthyl ring to any extent, including but Snot limited to the following: (a) JWH-175 ((1-pentylindol-3-yl)naphthalen-1-ylmethane); (b) JWH-184 (3-[(4-methyl-l-naphthalenyl)methyl]-1-pentyl-lH-indole) Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl) pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including but not limited to the following: (a) JWH-307 ((5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-l-ylmethanone). Naphthylmethylindenes. Any compound containing a naphthymethylidene indene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent, including but not limited to the following: (a) JWH-176 (1-([(lE)-3-pentylinden-1-ylidine]methyl)naphthalene). • Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including but not limited to the following: (a) JWH-203 (2-(2-chlorophenyl)-1-(1-pentylindol-3-yl)ethanone; (b) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole); (c) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole); (d) JWH-302 (2-(3-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone); (e) RCS-8 (also BTW-8, BTM-8 and SR-18) (1-(1-(2-cyclohexylethyl)-1H-indol-3- yl)-2-(2-methoxyphenyl)ethanone). Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent, including but not limited to the following: (a) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5- (2-methyloctan-2-yl)phenol) • and its homologues; 4 (b) CP 55,940 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]- 5-(2- • methyloctan-2-yl)phenol); (c) Cannabicyclohexanol (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-(2-methylnonan-2- yl)phenol). Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including but not limited to the following: (a) AM-679 (1-pentyl-3-(2-iodobenzoyl)indole); (b) AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone); (c) Pravadoline (WIN 48,098) ((4-methoxyphenyl)-[2-methyl-1-(2-morpholin-4- ylethyl)indol-3-yl]methanone); (d) RCS-4 (2-(4-methoxyphenyl)(1-pentyl-lH-indol-3-yl)methanone). Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl group, whether or not further substituted in the adamantyl ring system to any extent, including but not limited to the following: • (a) AM-1248 (1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-l-oyl)indole). Additional Compounds. Any substance containing any of the following compounds: (a) HU-210 ((6aR,l0aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol); (b) HU-211 ((6aS,l0aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,l 0,l 0a-tetrahydrobenzo [c]chromen-l-ol); (c) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7- dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol); (d) HU-331 ((3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-l- yl]-5-pentyl-2,5-cyclohexadiene-l,4-dione). SYNTHETIC PSYCHEDELIC/HALLUCINOGEN: Any chemical compound that mimics the effects of any federally controlled Schedule I substance, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance, and their analog (including salts, isomers (whether optical, positional, or geometric), esters, ethers and salts of isomers) containing substances which have a psychedelic/hallucinogenic effect on the central nervous system and/or brain, including those examples found in the Schedules of Article II of the Illinois Control Substances Act (720 ILCS 570/201 et seq.), as amended from time to time, or otherwise prohibited under federal or state law, and further including, but not limited to, • the following: 5 • (a) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E); (b) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine (2C-D); (c) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C); (d) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I); (e) 2-(4-(Ethylthio)-2,5-dimethoxyphenyl)ethanamine (2C-T-2); (0 2-(4-(Isopropylthio)-2,5-dimethoxyphenyl)ethanamine (2C-T-4); (g) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H); (h) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); (i) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P); (j) 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (other names: methoxetamine; MXE); (k) 2-(5-methoxy-lH-indol-3-yl)-N,N-dimethylethanamine (other names: 5-methoxy- N,N-dimethyltryptamine; 5-MeO-DMT) (1) 4-Phosphoryloxy-N,N-diethyltryptamine (other names: ethocybin; CEY-19). SYNTHETIC STIMULANT: Any chemical compound that mimics the effects of any federally controlled Schedule I substance such as cathinone, methcathinone, MDMA and MDEA, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance, and their analog (including salts, isomers (whether optical, positional, or geometric), and salts of isomers) containing substances which have a stimulant effect on the central nervous system, including those examples found in the Schedules of Article II of the Illinois Control Substances Act (720 ILCS 570/201 et seq.), as amended from time to time, or • otherwise prohibited under federal or state law, and further including, but not limited to, the following: (a) 3-Fluoromethcathinone; (b) 4-Fluoromethcathinone (other name: flephedrone); (c) 3,4-Methylenedioxymethcathinone (other names: methylone; MDMC); (d) 3,4-Methylenedioxypyrovalerone (other name: MDPV); (e) 4-Methylmethcathinon (other names: mephedrone; 4-MMC); (0 4-Methoxymethcathinone (other names: methedrone; bk-PMMA; PMMC); (g) 4-Ethylmethcathinone (other name: 4-EMC); (h) Ethcathinone; (i) Beta-keto-N-methylbenzodioxyolylpropylamine (other names: butylone; bk-MBDB); 0) Napthylpyrovalerone (other names: naphyrone; NRG-1); (k) N,N-dimethylcathinone (other name: metamfepramone); (1) Alpha-pyrrolidinopropiophenone (other name: alpha-PPP); (m)4-methoxy-alpha-pyrrolidinopropiophenone (other name: MOPPP); (n) 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (other name: MDPPP); (o) Alpha-pyrrolidinovalerophenone (other name: alpha-PVP); (p) 6,7-kihydro-5H-indeno(5,6-d)-1,3-dioxal-6-amine) (other name: MDAI); (q) Any compound that is structurally derived from 2-amino-I-phenyl-l-propanone by modification or substitution in any of the following ways: • 6 (1) in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or • halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents; (2) at the 3-position with an alkyl substituent; (3) at the nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; (4) or by inclusion of the nitrogen atom in a cyclic structure. TABLE 10.26.010: Table 10.26.010 shall read as follows: 8-Ball 2010 Aztec Gold Aztec Midnight Wind Back Draft Bad 2 the Bone Banana Cream Nuke Bayou Blaster Black Diamond Black Magic Salvia Black Mamba Blueberry Hayze Bombay Blue Buzz C3 C4 C4 Herbal Incense Caneff Cherry Bomb Chill X Chronic Spice Chill Out Citrus Colorado Chronic Da Block Dark Night I1 Demon Diamond Spirit Dragon Spice D-Rail Dream Earthquake Eru tion Spice Euphoria EX-SES EX-SES Platinum EX-SES Platinum Blueberry EX-SES Cherry EX-SES Strawberry • EX-SES Platinum Cherry EX-SES Platinum Strawberry EX-SES Platinum Vanilla EX-SES Vanilla Fire Bird Ultimate Forest humus Freedom Fully Loaded Funky Monkey Funky Monkey XXXX G Four G Greenies Caramel Crunch Genie Gold Spirit Spice Green Monkey Chronic Salvia Greenies Strawberry Heaven Improved Heavenscent Suave Humboldt Gold Jamaican Gold K Royal K 1 Gravity K 1 Orbit K2 K2 (unknown variety) K2 Amazonian Shelter K2 Blonde K2 Blue K2 Blueberry K2 Citron K2 Citron K2 K2 Cloud 9 K2 Kryptonite K2 Latte K2 Mint K2 Orisha Black Magic Max K2 Orisha Max K2 Orisha Regular K2 Orisha Super K2 Orisha White Magic Super K2 Peach K2 Pina Colada K2 Pineapple Express K2 Pink K2 Pink Panties K2 Sex K2 Silver K2 Solid Sex on the Mountain K2 Standard K2 Strawberry K2 Summit K2 Summit Coffee Work K2 Summit Space K2 Thai Dream K2 Ultra K2 Watermelon K3 K3 Blueberry K3 Cosmic Blend K3 Dusk • K3 Grape K3 Heaven Improved K3 Heaven Legal 7 K3 Kryptonite K3 Legal K3 Le al —Earth (silver) • K3 Legal —Original (Black) K3 Level — Sea (Silver) K3 Legal — Sun (Black) K3 Mango K3 Original K3 Original Improved K3 Strawberry K3 Sun K3 Sun Improved K3 Sun Legal K3 XXX K4 Bubble Bubble K4 Gold K4 Silver K4 Summit Remix Kind Spice Legal Eagle Legal Ea le Apple Love Potion 69 Love Strawberry Magic Dragon Platinum Magic Gold Magic Silver Mega Bomb Magic Spice Mid-Atlantic Exemplar Midnight Chill Mellon K2 MNGB Peppermint MNGB Pinata Colada MNGB Pina Colada MNGB Tropical Thunder Moe Joe Fire MNGB Almond-Vanilla Mr. Smiley's MTN-787 MNGB Spear Mint Naughty Nights New Improved K3 Cosmic Blend Mo'o New Improved Kryptonite New K3 Earth Mystery New K3 Improved New K3 Sea Improved New Improved K3 Dynamite Nitro Ocean Blue New Improved K3 Kryptonite p.e.p. pourri Love Strawberry p.e.p. pourn Original Spearmint New K3 Heaven p.e.p. pourri X Blueberry Pie K4 Purple Haze New-Kron Bomb Pink Tiger Platinum Strawberry . Paradise POW Rasta Citrus Spice p.e.p. pourri Twisted Vanilla Pulse Samurai Spirit Pineapple Redbird Scope Wildberry Potpourri Scope Vanilla Shanti Spice Blueberry Rebel Spice Shanti Spice Skunk Sativah Silent Black Space Sence Smoke Plus S ice Gold Si. S. Werve Spice Diamond Spicey Regular XXX Blueberry Smoke Spice Tropical Synergy Spicey Ultra Strong XXX Vanilla Spice Artic Synergy Spicey Ultra Strong XXX Spike 99 Strawberry Spice Silver S icylicious Spike 99 Ultra Cherry Spicey Regular XXX Spike 99 Ultra Blueberry Spike Gold Strawberry Spicey XXX Spike Diamond Stinger Spike 99 Ultra Spike Silver Super Kush Spike 99 Strawberry Summer Skyy SYN Chill Spike Maxx Swagger Grape SYN Incense Spearmint Strength Cinnamon SYN Incense Smooth SYN Smooth Super Summit SYN Lemon Lime 42 SYN Suave • SYN Incense Lemon Lime SYN Spearmint #2 SYN Vanilla#2 8 SYN Lemon Lime SYN Vanilla Time Warp SYN Spearmint Tezcatli oca Unknown cigarette SYN Swagg Ultra Cloud 10 Voodoo Child Texas Gold Utopia-Blue Berry Voodoo Remix (black package) Tribal Warrior Voodoo Remix Who Dat Herbal Incense Utopia Who Dat Wood Stock Voodoo Magic Voodoo Remix (orange Wicked X package) Winter Boost Yucatan Fire Yucatan Fire Smoke XTREME Spice Zombie World Bliss Blue Light Blue Silk Charge Cosmic Blast Disco Concentrate Bath Salts Ivory Snow Ocean Burst Pure Ivory Purple Wave Snow Leopard Stardust (Star Dust) Tranquility Bath Salts White Dove White Knight White Rush Zeus 2 Ivory Wave White Lightening Hurricane Charlie White Girl Blue Magic Silverback Bath Salts Raving Dragon Cloud 9 Purple Tranquility Zoom 2 Aura Red Dove Vanilla Sky White Horse Ivory Coast Energy 1 MDPK Magic Super Coke Am ed Rave SnowBlind Crystal Bubbly Eight Ballz White Water Rapid Avalanche Bizaro Voodoo Powder Spice Spice Smoked Blend Black Mamba Zohai Mr. Nice Guy Genie Earth Impact Galaxy Gold Space Truckin' Solar Moon Rocks Aroma Scope Sky High Red X Dawn 10.26.020: SALE OR DELIVERY: It shall be unlawful for any person to advertise, display, sell, offer for sale, give away or deliver any product containing a synthetic cannabinoid, synthetic stimulant or synthetic psychedelic/hallucinogen, including but not limited to those products listed in Table 10.26.010 set forth herein. 10.26.030: POSSESSION: It shall be unlawful for any person to knowingly possess a product containing a synthetic cannabinoid, synthetic stimulant or synthetic psychedelic/hallucinogen, including but not limited to those products listed in Table 10.26.010 set forth herein. 9 • 10.26.040: USE: It shall be unlawful for any person to use, inject, ingest, inhale, or otherwise introduce into the human body, or to be under the influence of, a synthetic cannabinoid, synthetic stimulant or synthetic psychedelic/hallucinogen, including but not limited to those products listed in Table 10.26.010 set forth herein. 10.26.050: MANUFACTURE: It shall be unlawful for any person to manufacture, or assemble the ingredients with the intent to manufacture a synthetic cannabinoid, a synthetic stimulant, or a synthetic psychedelic/hallucinogen, including but not limited to those listed in Table 10.26.010 set forth herein. In determining intent under this subsection, a trier of fact may take into consideration, among other things: the proximity of the product or ingredients to drug paraphernalia; the presence of the product or ingredients on or within drug paraphernalia; and the proximity of the product or ingredients to a different controlled substance. 10.26.060: UNLAWFUL TO ADVERTISE: It is unlawful for any person to place in any newspaper, magazine, handbill or other publication any advertisement, knowing, or under circumstances where one should reasonably know, that the purpose of the advertisement, in whole or in part, is to promote the sale of a synthetic • cannabinoid, synthetic stimulant or synthetic psychedelic/hallucinogen, including but not limited to those products listed in Table 10.26.010 set forth herein. 10.26.070: PUBLIC NUISANCE DECLARED: Any store, place, or premises from which or in which any synthetic cannabinoid, synthetic stimulant or synthetic psychedelic/hallucinogen, including but not limited to those products listed in Table 10.26.010 set forth herein, are kept for sale, offered for sale, sold, manufactured, possessed with intent to deliver, or delivered for any commercial consideration, is declared to be a public nuisance. A. Whenever the city manager or the city manager's designee reasonably believes that any premises constitutes a public nuisance as described in this section, the city manager or such designee may bring an action to abate the nuisance in a court of competent jurisdiction or in the city's division of administrative hearings. B. Upon being satisfied by affidavits or other sworn evidence that an alleged public nuisance exists, the presiding authority may, without bond, enter a temporary restraining order to enjoin any defendant from maintaining the nuisance and may, without bond, enter a preliminary injunction restraining any defendant from removing or interfering with any property used in connection with the public nuisance. 10 C. If during the proceedings and hearings upon the merits the existence of the nuisance • is established, and it is established that the nuisance was maintained with the intentional, knowing or reckless permission of the owner, or an agent of the owner managing the premises, the court shall enter an order restraining all persons from maintaining or permitting the nuisance and from using the premises for a period of one year thereafter. However an owner, lessee, or other occupant thereof may use the premises if the owner gives bond with sufficient security or surety, in an amount between $5,000 and $10,000 approved by the court, payable to the "City of Elgin." The bond shall include a condition that no offense specified in this chapter shall be committed at, in, or upon the property described, and a condition that the principal obligor and surety assume responsibility for any fine, costs, or damages incurred by any person resulting from such an offense. 10.26.080: EXEMPTIONS: This chapter shall not apply to items used in the preparation, compounding, packaging, labeling, or other use of synthetic cannabinoids, synthetic stimulants or synthetic psychedelic/hallucinogens as an incident to administering or dispensing such products in the course of a person's professional practice, or as an incident to lawful research, teaching, or chemical analysis and not for sale. 10.26.090: PENALTIES: • Any person found in violation of any of the provisions or failing to comply with any of the mandatory requirements of this chapter shall be guilty of an offense. Any person found to be in violation of Section 10.26.020 (Sale or Delivery), Section 10.26.050 (Manufacture), Section 10.26.060 (Unlawful to Advertise), or Section 10.26.070 (Public Nuisance Declared) shall, upon conviction, be punishable by a fine of not less than One Thousand Dollars ($1,000.00). Any person found to be in violation of Section 10.26.030 (Possession) or Section 10.26.040 (Use) shall, upon conviction, be punishable by a fine of not less than Five Hundred Dollars ($500.00). In addition, the following provisions shall apply with respect to any fine or penalty to be imposed for a violation of this chapter: A. In addition to the payment of the aforesaid fine, any person found to be in violation of this chapter shall also, upon conviction, be required to complete not less than fifty (50) hours and not more than two hundred (200) hours of community service or community restitution. B. Any person shall be guilty of a separate offense for each and every day during any portion of which any violation of any provision of this chapter is committed, continued or permitted by any such person, and the person shall be punished accordingly. C. The court shall consider as an aggravating factor for the purpose of imposing any fine or penalty for conviction of an offense under this chapter the following: 11 I. That the sale, delivery, possession, use or manufacture occurred (i) on any real property comprising any school, or (ii) on any conveyance owned, leased or contracted for by a school or school district to transport students to or from a school or a school-related activity, or (iii) on any public way within 1,000 feet of any real property comprising any school or (iv) on any public way within 1,000 feet of any conveyance owned, leased or contracted for by a school or school district to transport students to or from a school or a school-related activity. 2. That the sale or delivery was by a person that is at least eighteen (18) years of age at the time of the offense, to any person under eighteen (18) years of age at the time of the offense. 3. Any other pertinent factor or circumstance. Section 2. Severability. If any provision, clause, sentence, paragraph, section or part of this ordinance or application thereof to any person or circumstance, shall for any reason be adjudged by a court of competent jurisdiction to be unconstitutional or invalid, said judgment shall not affect, impair or invalidate the remainder of this ordinance and the application of such provision to other persons or circumstances, but shall be confined in its operation to the provision, clause, sentence, paragraph, section or part thereof directly involved in the controversy in which such judgment shall have been rendered and to the person or circumstances involved. It is hereby declared to be the legislative intent of the City Council that this ordinance would have been adopted had such unconstitutional or invalid provisions; clause, sentence, • paragraph, section or part thereof not been included. Section 3. That all ordinances or parts of ordinances in conflict with the provisions of this ordinance be and are hereby repealed. Section 4. That this ordinance shall be in full force and effect upon its passage and publication in the manner provided by law. David J. tain, ayor Presented: September 26, 2012 Passed: September 26, 2012 Omnibus Vote: Yeas: 7 Nays: 0 Recorded: September 26, 2012 Published: September 28, 2012 Attest: 'r s r Kimberly Dewis, Ci y Cler • 12